Statement on Sir Philip Rutnam’s claim for unfair (constructive) dismissal
Announcing the commencement of legal action from former Home Office Permanent Secretary Sir Philip Rutnam, FDA General Secretary Dave Penman yesterday said:
“On 29 February 2020, Sir Philip Rutnam resigned as Permanent Secretary of the Home Office, indicating that he intended to pursue a claim of constructive dismissal. Following his resignation, the FDA instructed Gavin Mansfield QC, Head of Littleton Chambers and employment law specialist, as Counsel to advise Sir Philip, supported by Clive Howard, Senior Principal Lawyer, Employment and Partnership at Slater and Gordon.
“This morning, Sir Philip, with the support of his legal team and the FDA, submitted a claim to the employment tribunal for unfair (constructive) dismissal and whistleblowing against the Home Secretary.
“Sir Philip will not be making any further comment at this time.”
Notes For Editors
- The FDA is the union for senior managers and professionals in public service, representing more than 18,000 members at grades HEO and above. Membership includes senior civil servants, government policy advisors, prosecutors, diplomats, tax professionals, economists, solicitors and other professionals working across the Government and the NHS.
- The FDA (formerly the First Division Association) should be referred to simply as "The FDA" and can be described as "the senior public servants' union".
- The FDA can be found on Twitter @FDA_union. General Secretary Dave Penman tweets as @FDAGenSec.
For more information contact:
FDA Communications Officer Tommy Newell on 07738 729 145 or email@example.com
FDA Communications Officer Scott Dobson on 07727 869 640 or firstname.lastname@example.org
Latest News from
Culture sector rescue package highlights failure of current funding models07/07/2020 12:25:00
The FDA represents staff working in museums and galleries across the UK.
Departure of Sir Mark Sedwill: FDA response29/06/2020 16:20:00
FDA General Secretary Dave Penman yesterday responded to the departure of Cabinet Secretary Sir Mark Sedwill.
FDA welcomes ‘historic moment for House of Commons’ as MPs put trust in independent process24/06/2020 16:20:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons debate on establishing the new Independent Expert Panel to deal with complaints of bullying and harassment against MPs.
Response to DFID and FCO merger17/06/2020 12:25:00
FDA National Officer Allan Sampson yesterday responded to the announcement that the Department for International Development (DFID) and the Foreign and Commonwealth Office (FCO) are to merge
HM Courts and Tribunals Service is failing to ensure safety, says FDA15/06/2020 13:15:00
As the recognised representatives of prosecutors and managers in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with HM Courts and Tribunals Service (HMCTS) about its approach to reopening courts across England and Wales.
FDA secures pay rise for Welsh Government staff08/06/2020 14:25:00
FDA members in Welsh Government have voted to accept a 2.5% pay award for 2020, with a resounding 98% voting to accept the offer.
FDA and Prospect joint press release: Hybrid Parliament must continue01/06/2020 14:10:00
Last week the government refused to renew the standing order to continue with the hybrid Parliament and Jacob Rees-Mogg reassured the House that a risk assessment had been done.
FDA condemns “reckless” decision to return to physical Parliament21/05/2020 12:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to Leader of the House Jacob Rees-Mogg, who has made the decision that the government will not renew the standing orders for a hybrid Parliament.